D-Index & Metrics Best Publications
Microbiology
Spain
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 87 Citations 32,318 576 World Ranking 200 National Ranking 2
Medicine D-index 97 Citations 43,687 776 World Ranking 4272 National Ranking 59

Research.com Recognitions

Awards & Achievements

2022 - Research.com Microbiology in Spain Leader Award

2012 - European Society for Clinical Microbiology and Infectious Diseases Excellence Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Antibiotics

His main research concerns Internal medicine, Surgery, Microbiology, Incidence and Immunology. His studies in Internal medicine integrate themes in fields like Gastroenterology and Bacteremia. His Surgery research includes elements of Cohort study and Intensive care unit.

His Microbiology study frequently links to adjacent areas such as Virology. His Incidence research integrates issues from Odds ratio, Intensive care medicine, Epidemiology and Risk factor. Emilio Bouza has included themes like Fever of unknown origin, Acquired immunodeficiency syndrome and Tuberculosis, Mycobacterium tuberculosis in his Immunology study.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America (2140 citations)
  • Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) (532 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Microbiology, Surgery, Intensive care medicine and Bacteremia. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Immunology. His work carried out in the field of Microbiology brings together such families of science as Genotype and Virology.

His Virology research includes themes of Tuberculosis and Mycobacterium tuberculosis. Emilio Bouza frequently studies issues relating to Intensive care unit and Surgery. Emilio Bouza studies Intensive care which is a part of Intensive care medicine.

He most often published in these fields:

  • Internal medicine (31.35%)
  • Microbiology (30.04%)
  • Surgery (24.70%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (31.35%)
  • Microbiology (30.04%)
  • Intensive care medicine (16.53%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Internal medicine, Microbiology, Intensive care medicine, In patient and Surgery. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Clostridium difficile. Emilio Bouza usually deals with Microbiology and limits it to topics linked to Biofilm and Staphylococcus aureus.

Aspergillosis and Transplantation is closely connected to Disease in his research, which is encompassed under the umbrella topic of Intensive care medicine. A large part of his Surgery studies is devoted to Catheter. His Infective endocarditis research incorporates elements of Bacteremia, Endocarditis and Cohort.

Between 2016 and 2021, his most popular works were:

  • Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection (398 citations)
  • Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach. (93 citations)
  • Dalbavancin in the treatment of different gram-positive infections: a real-life experience (58 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Antibiotics
  • Disease

Internal medicine, Microbiology, Intensive care medicine, Prospective cohort study and Retrospective cohort study are his primary areas of study. His biological study spans a wide range of topics, including Clostridium difficile, Medical microbiology and Surgery. In his research, Voriconazole, Aspergillosis, Transplantation, Disease and Bronchoalveolar lavage is intimately related to Cirrhosis, which falls under the overarching field of Surgery.

In the field of Microbiology, his study on Micafungin overlaps with subjects such as Species level. The Intensive care medicine study combines topics in areas such as Enterococcus spp and Antibiotic resistance. His Retrospective cohort study research is multidisciplinary, incorporating perspectives in Odds ratio, Mortality rate and Clinical significance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America

Leonard A. Mermel;Michael Allon;Emilio Bouza;Donald E. Craven.
Clinical Infectious Diseases (2009)

3184 Citations

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi.
Clinical Infectious Diseases (2007)

720 Citations

A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE

Sa Danner;A Carr;Jm Leonard;Lm Lehman.
The New England Journal of Medicine (1995)

652 Citations

Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus

Juan Berenguer;Santiago Moreno;Fernando Laguna;Teresa Vicente.
The New England Journal of Medicine (1992)

569 Citations

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

A. Skiada;L. Pagano;A. Groll;S. Zimmerli.
Clinical Microbiology and Infection (2011)

520 Citations

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection

Mark H. Wilcox;Dale N. Gerding;Ian R. Poxton;Ciaran Kelly.
The New England Journal of Medicine (2017)

497 Citations

Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease

Patricia Muñoz;Emilio Bouza;Manuel Cuenca-Estrella;Jose María Eiros.
Clinical Infectious Diseases (2005)

480 Citations

Mycobacterium tuberculosis infection in recipients of solid organ transplants.

Patricia Muñoz;Claudia Rodríguez;Emilio Bouza.
Clinical Infectious Diseases (2005)

368 Citations

Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.

J. Guinea;M. Torres-Narbona;P. Gijón;P. Muñoz.
Clinical Microbiology and Infection (2010)

365 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Emilio Bouza

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 124

Mark H. Wilcox

Mark H. Wilcox

University of Leeds

Publications: 121

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 118

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 116

David W. Denning

David W. Denning

University of Manchester

Publications: 95

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 89

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 86

Ed J. Kuijper

Ed J. Kuijper

Leiden University Medical Center

Publications: 81

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 78

Antoni Torres

Antoni Torres

University of Barcelona

Publications: 69

Emmanuel Roilides

Emmanuel Roilides

Aristotle University of Thessaloniki

Publications: 62

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 61

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 59

Jean-François Timsit

Jean-François Timsit

Université Paris Cité

Publications: 58

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 58

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 57

Trending Scientists

Martin D.D. Evans

Martin D.D. Evans

Georgetown University

Goran Z. Mashanovich

Goran Z. Mashanovich

University of Southampton

Jeffrey P. Calame

Jeffrey P. Calame

United States Naval Research Laboratory

Arthur D. Kuo

Arthur D. Kuo

University of Calgary

Gert von Helden

Gert von Helden

Fritz Haber Institute of the Max Planck Society

Francesco Gasparrini

Francesco Gasparrini

Sapienza University of Rome

Jeffrey R. Mann

Jeffrey R. Mann

Monash University

Kevin J. McGraw

Kevin J. McGraw

Arizona State University

Kyung-Tae Lee

Kyung-Tae Lee

Kyung Hee University

Sung Hee Baek

Sung Hee Baek

Seoul National University

Marina Alberti

Marina Alberti

University of Washington

Henrik Kylin

Henrik Kylin

North-West University

Stephen M. Wilson

Stephen M. Wilson

Vanderbilt University Medical Center

Catherine E. Ross

Catherine E. Ross

The University of Texas at Austin

Kasia Stepniewska

Kasia Stepniewska

University of Oxford

A. John Iafrate

A. John Iafrate

Harvard University

Something went wrong. Please try again later.